To investigate whether AB928 can shield CAR T cells from adenosine-mediated suppression, we cocultured anti-EpCAM CAR T cells and Panc02-EpCAM tumour cells in the presence or absence of inhibiting concentrations of NECA and serially titrated AB928. This evidence concerns the gene EPCAM and neoplasm.